Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mah

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Occupational Medicine (Philadelphia, Pa.)|May 20, 1998
Reducing workers' compensation fraud: a deterrent approachD R Mah
The West Indian Medical Journal|April 24, 2014
A case of systemic cryptococcal disease in HIV infectionR Mah-Lee, G Barrow
Journal of Endodontics|June 1, 1996
Periapical changes after orthodontic movement of root-filled ferret caninesR Mah, G R Holland, E Pehowich
Journal of Bacteriology|April 1, 1993
Accumulation of bldA-specified tRNA is temporally regulated in Streptomyces coelicolor A3(2)B K Leskiw, R Mah, E J Lawlor, et al.
Stereotactic and Functional Neurosurgery|January 1, 1997
Robotic multimodality stereotactic brain tissue identification: work in progressR Andrews, R Mah, A Galvagni, et al.
Applied Clinical Informatics|February 14, 2024
Improving Vaccine Equity: How Community Engagement and Informatics Facilitate Health System Outreach to Underrepresented GroupsSerena J Xie, Nicholas R Mah, Lisa Chew, et al.
Stereotactic and Functional Neurosurgery|June 15, 2000
Multimodality stereotactic brain tissue identification: the NASA smart probe projectR Andrews, R Mah, A Aghevli, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonistM Gerspacher, A von Sprecher, R Mah, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Dual neurokinin NK(1)/NK(2) antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propionamidesM Gerspacher, L La Vecchia, R Mah, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1996
Intestinal absorption studies on peptide mimetic alpha-methyldopa prodrugsH P Wang, H H Lu, J S Lee, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Occupational Medicine (Philadelphia, Pa.)|May 20, 1998
Reducing workers' compensation fraud: a deterrent approachD R Mah
The West Indian Medical Journal|April 24, 2014
A case of systemic cryptococcal disease in HIV infectionR Mah-Lee, G Barrow
Journal of Endodontics|June 1, 1996
Periapical changes after orthodontic movement of root-filled ferret caninesR Mah, G R Holland, E Pehowich
Journal of Bacteriology|April 1, 1993
Accumulation of bldA-specified tRNA is temporally regulated in Streptomyces coelicolor A3(2)B K Leskiw, R Mah, E J Lawlor, et al.
Stereotactic and Functional Neurosurgery|January 1, 1997
Robotic multimodality stereotactic brain tissue identification: work in progressR Andrews, R Mah, A Galvagni, et al.
Applied Clinical Informatics|February 14, 2024
Improving Vaccine Equity: How Community Engagement and Informatics Facilitate Health System Outreach to Underrepresented GroupsSerena J Xie, Nicholas R Mah, Lisa Chew, et al.
Stereotactic and Functional Neurosurgery|June 15, 2000
Multimodality stereotactic brain tissue identification: the NASA smart probe projectR Andrews, R Mah, A Aghevli, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonistM Gerspacher, A von Sprecher, R Mah, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Dual neurokinin NK(1)/NK(2) antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propionamidesM Gerspacher, L La Vecchia, R Mah, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1996
Intestinal absorption studies on peptide mimetic alpha-methyldopa prodrugsH P Wang, H H Lu, J S Lee, et al.
Pageof 2